Puma Biotechnology Inc (PBYI) has a current stock price of $3.69. During the previous trading session, the stock witnessed a notable rise, reaching a high of $4.0 after opening at $3.69. The stock’s low for the day was $2.0, and it eventually closed at $3.29.
Puma Biotechnology Inc’s stock has had a calm market performance.
52-week price history of PBYI Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Puma Biotechnology Inc’s current trading price is -9.11% away from its 52-week high, while its distance from the 52-week low is 65.84%. The stock’s price range during this period has fluctuated between $2.22 and $4.06. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 1.35 million for the day, which was evidently higher than the average daily volume of 0.36 million over the last three months.
Financial Performance and Market Capitalization
Puma Biotechnology Inc (PBYI) has experienced a quarterly rise of 20.20% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 185.87M and boasts a workforce of 172 employees.
Analysts’ Ratings For Puma Biotechnology Inc
As of right now, 0 analyst is rating Puma Biotechnology Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.26, with a change in price of +0.45. Similarly, Puma Biotechnology Inc recorded 355,527 in trading volume during the last 100 days, posting a change of +13.89%.
PBYI Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for PBYI stands at 0.47. Similarly, the long-term debt-to-equity ratio is also 0.10.
PBYI Stock Stochastic Average
The raw stochastic average for Puma Biotechnology Inc over the last 50 days is presently at 83.54%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 91.35%. Further, the company’s Stochastic %K and %D values for the last 20 days were 57.12% and 41.09%, respectively.
PBYI Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The index has shown a price loss of -8.44% this year. Over the last six months, there has been a weaker performance of 27.68%. The price of PBYI fallen by 4.83% during the last 30 days period. For the last 5-days stocks have improved 20.20%.
